Skip to content

OMCL

Omnicell, Inc.

NASDAQ · Healthcare · Medical - Healthcare Information Services · US

$34.37
−1.29%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue1.2B1.2B1.1B1.1B1.3B
Cost of Revenue688.6M676.8M641.2M647.2M707.0M
Gross Profit558.1M508.0M471.0M499.9M589.0M
Operating Expenses
R&D Expense88.4M87.7M90.4M93.3M105.0M
SG&A Expense410.8M408.6M380.3M426.0M486.3M
General & Admin Expense
Selling & Marketing Expense
Other Expenses
Total Operating Expenses499.2M496.4M470.7M519.3M591.3M
Cost and Expenses1.2B1.2B1.1B1.2B1.3B
Operating Income (EBIT)59.0M11.7M337.0K(19.3M)(2.3M)
Non-Operating
Interest Income6.1M11.9M24.9M14.8M
Interest Expense3.9M3.9M4.5M130.0K
Net Interest Income2.2M8.0M20.4M14.8M(130.0K)
Other Non-Op Income/Expense2.2M(340.0K)25.3M(779.0K)(130.0K)
Non-Operating Income (excl Interest)(4.0M)(3.6M)(29.8M)(3.8M)
EBT (Pre-Tax Income)61.1M11.3M25.6M(20.1M)(2.5M)
Income Tax Expense22.1M9.3M13.1M263.0K(8.1M)
Bottom Line
Net Income39.1M2.1M12.5M(20.4M)5.6M
Earnings from Cont. Ops39.1M2.1M12.5M(20.4M)5.6M
Earnings from Discont. Ops
Bottom Line Net Income39.1M2.1M12.5M(20.4M)5.6M
Per Share
Basic EPS$0.85$0.04$0.27($0.45)$0.13
Diluted EPS$0.84$0.04$0.27($0.45)$0.12
Revenue Per Share$27.42$25.78$24.15$25.37$29.19
Shares
Basic Shares Outstanding45.5M46.0M46.0M45.2M44.4M
Diluted Shares Outstanding46.1M46.4M46.3M45.2M45.9M
Profitability Metrics
EBITDA106.1M101.9M119.9M80.0M96.8M
D&A43.1M86.6M89.8M95.6M99.2M
EBIT62.9M15.2M30.1M(15.6M)(2.3M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026